Nautilus Biotechnology, Inc. Profile Avatar - Palmy Investing

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end…

Biotechnology
US, Seattle [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Nautilus Biotechnology, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Nautilus Biotechnology, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Nautilus Biotechnology, Inc..

End of NAUT's Analysis
CIK: 1808805 CUSIP: 63909J108 ISIN: US63909J1088 LEI: - UEI: -
Secondary Listings
NAUT has no secondary listings inside our databases.